As a high-level comprehensive medical service platform, the Qianhai Yihe International Medical Center is committed to providing patients with a warm, high-quality "heartfelt" medical experience. It integrates the hospital's strong in-house expert team with more than 100 specially invited external specialists to deliver personalized, high-quality care. Covering 120,000 square meters, the center includes outpatient clinics, premium health screening, and 600 premium beds, and will become the largest high-end medical ward within a domestic tertiary general hospital. In addition to high-quality comprehensive medical services, it also features a premium obstetrics and postpartum (confinement) center, a specialty rehabilitation department, and an anti-aging center, aiming to offer patients a one-stop health management and full-scope medical service that combines customized premium screening, whole-cycle diagnosis and treatment, and comprehensive health management.

Founded in 1910, the First Affiliated Hospital, Sun Yat-sen University is a national Grade-A tertiary hospital and a national regional medical center, with 5 national key disciplines and 34 national key clinical specialties. The hospital is internationally leading in critical care medicine, organ transplantation, and cardiovascular and cerebrovascular care, and is equipped with world-class medical facilities and an international medical center. The Nansha campus houses an independent international medical center providing premium medical services aligned with international standards.

Established in 1964, the Sun Yat-sen University Cancer Center (Sun Yat-sen University Affiliated Cancer Hospital, Sun Yat-sen University Cancer Institute) is one of the four earliest cancer hospitals founded after the establishment of the People's Republic of China. As a national "first-tier" cancer specialty hospital, the Center is the largest and most academically powerful oncology base in South China, integrating medical care, teaching, research, and prevention. It hosts national research platforms including a National Key Discipline (Oncology) and the State Key Laboratory of Oncology in South China, and leads internationally in the diagnosis and treatment of common and complex tumors such as nasopharyngeal carcinoma, gastrointestinal tumors, lung cancer, and lymphoma. In particular, its nasopharyngeal carcinoma diagnosis and treatment technology is hailed as the "China Solution" that sets global standards.

Founded in 1899, Guangzhou First People's Hospital (the Second Affiliated Hospital of South China University of Technology) is one of Guangdong Province's first Grade-A tertiary hospitals. It consists of three campuses — the main campus, Nansha Hospital, and the Hedong Branch — and is home to the renowned "Guangzhou Digestive Diseases Center." Gastroenterology and Geriatrics are national key clinical specialties, and digestive medicine is a key medical discipline of Guangdong Province. The hospital is equipped with the Da Vinci surgical robot, a 3.0T MRI, and other advanced equipment, and hosts a translational research center on Guangzhou International Bio-Island.

Founded in 1958, Foshan Fosun Chancheng Hospital (formerly Foshan Chancheng Central Hospital, abbreviated as "Foshan Chancheng") is a large Grade-A tertiary general hospital integrating medical care, rehabilitation, research, and teaching, with medical standards among the most advanced in the city. Backed by strong multidisciplinary strength and focused specialty clusters built around the "Three Treasures of Chancheng" (spine orthopedics, urology, and the maternal and child center), the hospital has successively completed a series of disciplinary upgrades including the national cardiovascular "Five Centers" and the "Stroke Center."

Guangdong Provincial People's Hospital (Guangdong Provincial Institute of Medicine) was founded in 1946 and is one of the largest and strongest comprehensive hospitals in China. The hospital follows a "strong specialties, broad integration" model with cardiovascular medicine as its core pillar. Its cardiovascular disease treatment level has consistently ranked at the forefront nationally, with extremely high technical barriers in cardiothoracic surgery and cardiology. It was the first in mainland China to perform many international cutting-edge surgeries. As a designated medical institution under the "Hong Kong-Macao Drug and Device Connect" program, the hospital actively participates in the Greater Bay Area medical integration and provides international advanced drug and device treatment solutions to patients worldwide.